A Worldwide Survey on the Understanding of Psoriatic Disease Among Patients With Psoriasis and Psoriatic Arthritis

Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK Registry

NCT06172426 ·Status: COMPLETED

Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis

NCT02931838 ·Status: COMPLETED ·Phase: PHASE2

Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).

NCT04428411 ·Status: COMPLETED

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

NCT00162253 ·Status: TERMINATED ·Phase: PHASE2

ACT-128800 in Psoriasis

NCT00852670 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

NCT04908189 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Phase 4 Clinical Study of Brodalumab

NCT04183881 ·Status: COMPLETED ·Phase: PHASE4

Understanding Participation Habits Among Plaque Psoriasis Patients

NCT06338358 ·Status: NOT_YET_RECRUITING

A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis

NCT05744466 ·Status: RECRUITING

Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

NCT05908240 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs

NCT04908202 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Psoriasis Longitudinal Assessment and Registry

NCT00508547 ·Status: ACTIVE_NOT_RECRUITING

A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

NCT06952465 ·Status: ACTIVE_NOT_RECRUITING

Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis

NCT03624127 ·Status: COMPLETED ·Phase: PHASE3

Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis

NCT02144857 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis

NCT05153148 ·Status: COMPLETED ·Phase: PHASE2

Analysis Of The Influence Of Metabolic Syndrome On Treatment Efficacy With Anti-Tnf In Moderate-Severe Psoriasis In Real Clinical Practice.

NCT01753245 ·Status: UNKNOWN

Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment

NCT04632927 ·Status: COMPLETED ·Phase: PHASE3

Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis

NCT00707070 ·Status: UNKNOWN ·Phase: PHASE4

Immunologic Response to Secukinumab in Plaque Psoriasis

NCT02592018 ·Status: COMPLETED ·Phase: PHASE4

An Explorative Psoriasis Biomarker Study

NCT04394936 ·Status: TERMINATED ·Phase: NA

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

NCT02346240 ·Status: COMPLETED ·Phase: PHASE3

AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis

NCT00941031 ·Status: COMPLETED ·Phase: PHASE2

A Study of Ixekizumab in Participants With Active Psoriatic Arthritis

NCT01695239 ·Status: COMPLETED ·Phase: PHASE3

Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis

NCT01154101 ·Status: COMPLETED ·Phase: PHASE2